Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 226

1.

Transforming mental well-being for people with diabetes: research recommendations from Diabetes UK's 2019 Diabetes and Mental Well-Being Workshop.

Wylie TAF, Shah C, Connor R, Farmer AJ, Ismail K, Millar B, Morris A, Reynolds RM, Robertson E, Swindell R, Warren E, Holt RIG.

Diabet Med. 2019 Jun 8. doi: 10.1111/dme.14048. [Epub ahead of print]

PMID:
31177573
2.

Parametrized rectal dose and associations with late toxicity in prostate cancer radiotherapy.

Hamlett LJ, McPartlin AJ, Maile EJ, Webster G, Swindell R, Rowbottom CG, Choudhury A, Aitkenhead AH.

Br J Radiol. 2015 Oct;88(1054):20150110. doi: 10.1259/bjr.20150110. Epub 2015 Aug 6.

3.

Investigation of a Patient Reported Outcome tool to assess radiotherapy-related toxicity prospectively in patients with lung cancer.

Christodoulou M, McCloskey P, Stones N, Bayman N, Burt P, Chittalia A, Harris M, Lee L, Pemberton L, Sheikh H, Swindell R, Faivre-Finn C.

Radiother Oncol. 2014 Aug;112(2):244-9. doi: 10.1016/j.radonc.2014.07.008. Epub 2014 Aug 5.

PMID:
25107555
4.

Expression of hypoxia-inducible factor-1α predicts benefit from hypoxia modification in invasive bladder cancer.

Hunter BA, Eustace A, Irlam JJ, Valentine HR, Denley H, Oguejiofor KK, Swindell R, Hoskin PJ, Choudhury A, West CM.

Br J Cancer. 2014 Jul 29;111(3):437-43. doi: 10.1038/bjc.2014.315. Epub 2014 Jun 17.

5.

Use of Pre-Ablation Radioiodine-131 Scan to Assess the Impact of Surgical Volume and Specialisation following Thyroidectomy for Differentiated Thyroid Carcinoma.

Yap BK, Homer J, Parrott N, Loughran S, Murby B, Swindell R, Gandhi A.

Eur Thyroid J. 2013 Dec;2(4):275-81. doi: 10.1159/000355911. Epub 2013 Nov 20.

6.

Phase II Trial of Cetuximab and Conformal Radiotherapy Only in Locally Advanced Pancreatic Cancer with Concurrent Tissue Sampling Feasibility Study.

Rembielak AI, Jain P, Jackson AS, Green MM, Santorelli GR, Whitfield GA, Crellin A, Garcia-Alonso A, Radhakrishna G, Cullen J, Taylor MB, Swindell R, West CM, Valle J, Saleem A, Price PM.

Transl Oncol. 2014 Feb 1;7(1):55-64. eCollection 2014 Feb.

7.

CT scan does not predict optimal debulking in stage III-IV epithelial ovarian cancer: a multicentre validation study.

MacKintosh ML, Rahim R, Rajashanker B, Swindell R, Kirmani BH, Hunt J, Brockbank E, Barton DP, Clayton RD.

J Obstet Gynaecol. 2014 Jul;34(5):424-8. doi: 10.3109/01443615.2014.899330. Epub 2014 Apr 11.

PMID:
24725017
8.

Thrombosis in ovarian cancer: a case control study.

Metcalf RL, Fry DJ, Swindell R, McGurk A, Clamp AR, Jayson GC, Hasan J.

Br J Cancer. 2014 Mar 4;110(5):1118-24. doi: 10.1038/bjc.2014.3. Epub 2014 Jan 21.

9.

Phase II trial of sorafenib in advanced salivary adenoid cystic carcinoma of the head and neck.

Thomson DJ, Silva P, Denton K, Bonington S, Mak SK, Swindell R, Homer J, Sykes AJ, Lee LW, Yap BK, Slevin NJ.

Head Neck. 2015 Feb;37(2):182-7. doi: 10.1002/hed.23577. Epub 2014 Mar 13.

PMID:
24346857
10.

FGFR2, HER2 and cMet in gastric adenocarcinoma: detection, prognostic significance and assessment of downstream pathway activation.

Betts G, Valentine H, Pritchard S, Swindell R, Williams V, Morgan S, Griffiths EA, Welch I, West C, Womack C.

Virchows Arch. 2014 Feb;464(2):145-56. doi: 10.1007/s00428-013-1517-y. Epub 2013 Dec 4.

PMID:
24306956
11.

Evaluation of hypertension and proteinuria as markers of efficacy in antiangiogenic therapy for metastatic colorectal cancer.

Khoja L, Kumaran G, Zee YK, Murukesh N, Swindell R, Saunders MP, Clamp AR, Valle JW, Wilson G, Jayson GC, Hasan J.

J Clin Gastroenterol. 2014 May-Jun;48(5):430-4. doi: 10.1097/MCG.0b013e3182a8804c.

PMID:
24153157
12.

Five-year outcomes after iodine-125 seed brachytherapy for low-risk prostate cancer at three cancer centres in the UK.

Dickinson PD, Malik J, Mandall P, Swindell R, Bottomley D, Hoskin P, Logue JP, Wylie JP.

BJU Int. 2014 May;113(5):748-53. doi: 10.1111/bju.12358. Epub 2013 Dec 2.

13.

Insufficiency fractures in patients treated with pelvic radiotherapy and chemotherapy for uterine and cervical cancer.

Mehmood Q, Beardwood M, Swindell R, Greenhalgh S, Wareham T, Barraclough L, Livsey J, Davidson SE.

Eur J Cancer Care (Engl). 2014 Jan;23(1):43-50. doi: 10.1111/ecc.12105. Epub 2013 Jul 25.

PMID:
23889218
14.

Biochemical outcomes for patients with intermediate risk prostate cancer treated with I-125 interstitial brachytherapy monotherapy.

Tran AT, Mandall P, Swindell R, Hoskin PJ, Bottomley DM, Logue JP, Wylie JP.

Radiother Oncol. 2013 Nov;109(2):235-40. doi: 10.1016/j.radonc.2013.05.030. Epub 2013 Jul 9.

PMID:
23849172
15.

The case for including bowel urgency in toxicity reporting after pelvic cancer treatment.

Henson CC, Anandadas CN, Barraclough LH, Swindell R, West CM, Davidson SE.

J Natl Compr Canc Netw. 2013 Jul;11(7):827-33.

PMID:
23847219
16.

The largest UK single centre series using hypofractionated radical radiotherapy for NSCLC in the very elderly.

McPartlin AJ, Chaudhry S, Swindell R, Bayman N, Burt P, Chittalia A, Cootes J, Faivre Finn C, Harris M, Lander H, Lee L, Sheikh H, Pemberton L.

Lung Cancer. 2013 Jul;81(1):144. doi: 10.1016/j.lungcan.2013.03.010. Epub 2013 May 2. No abstract available.

PMID:
23643277
17.

Cisplatin plus capecitabine as first-line chemotherapy for recurrent or metastatic head and neck squamous cell cancer: experience outside of a trial setting.

McPartlin AJ, Mais K, Barker C, Swindell R, Mitchell K, Sykes A, Lee L, Yap B, Slevin NJ.

Chemotherapy. 2013;59(1):1-7. doi: 10.1159/000348816. Epub 2013 Apr 25.

PMID:
23635527
18.

Structured gastroenterological intervention and improved outcome for patients with chronic gastrointestinal symptoms following pelvic radiotherapy.

Henson CC, Davidson SE, Ang Y, Babbs C, Crampton J, Kelly M, Lal S, Limdi JK, Whatley G, Swindell R, Makin W, McLaughlin J.

Support Care Cancer. 2013 Aug;21(8):2255-65. doi: 10.1007/s00520-013-1782-y. Epub 2013 Mar 21.

PMID:
23512314
19.

Value of the Hospital Anxiety and Depression Scale in the follow up of head and neck cancer patients.

Joseph LA, Routledge JA, Burns MP, Swindell R, Sykes AJ, Slevin NJ, Davidson SE.

J Laryngol Otol. 2013 Mar;127(3):285-94. doi: 10.1017/S0022215113000078. Epub 2013 Feb 11.

PMID:
23398854
20.

Nasopharyngeal carcinoma: a retrospective review of demographics, treatment and patient outcome in a single centre.

Colaco RJ, Betts G, Donne A, Swindell R, Yap BK, Sykes AJ, Slevin NJ, Homer JJ, Lee LW.

Clin Oncol (R Coll Radiol). 2013 Mar;25(3):171-7. doi: 10.1016/j.clon.2012.10.006. Epub 2013 Jan 18. Review.

PMID:
23337060
21.

Lack of prognostic effect of carbonic anhydrase-9, hypoxia inducible factor-1α and bcl-2 in 286 patients with early squamous cell carcinoma of the glottic larynx treated with radiotherapy.

Douglas CM, Bernstein JM, Ormston VE, Hall RC, Merve A, Swindell R, Valentine HR, Slevin NJ, West CM, Homer JJ.

Clin Oncol (R Coll Radiol). 2013 Jan;25(1):59-65. doi: 10.1016/j.clon.2012.07.004. Epub 2012 Jul 25.

PMID:
22841149
22.

Dose-escalated hypofractionated intensity-modulated radiotherapy in high-risk carcinoma of the prostate: outcome and late toxicity.

Thomson D, Merrick S, Swindell R, Coote J, Kelly K, Stratford J, Wylie J, Cowan R, Elliott T, Logue J, Choudhury A, Livsey J.

Prostate Cancer. 2012;2012:450246. doi: 10.1155/2012/450246. Epub 2012 Jun 20.

23.

Prospective analysis of patient-reported late toxicity following pelvic radiotherapy for gynaecological cancer.

Barraclough LH, Routledge JA, Farnell DJ, Burns MP, Swindell R, Livsey JE, Davidson SE.

Radiother Oncol. 2012 Jun;103(3):327-32. doi: 10.1016/j.radonc.2012.04.018. Epub 2012 May 23.

PMID:
22633812
24.

University of the Third Age in Australia and New Zealand: Capitalising on the cognitive resources of older volunteers.

Swindell R, Vassella K, Morgan L, Sayer T.

Australas J Ageing. 2011 Dec;30(4):196-201. doi: 10.1111/j.1741-6612.2010.00476.x. Epub 2010 Oct 8.

PMID:
22176564
25.

Gastrointestinal symptoms after pelvic radiotherapy: a national survey of gastroenterologists.

Henson CC, Davidson SE, Lalji A, Symonds RP, Swindell R, Andreyev HJ.

Support Care Cancer. 2012 Sep;20(9):2129-39. doi: 10.1007/s00520-011-1323-5. Epub 2011 Nov 13.

PMID:
22081117
26.

Prediction of post-treatment trismus in head and neck cancer patients.

Lee R, Slevin N, Musgrove B, Swindell R, Molassiotis A.

Br J Oral Maxillofac Surg. 2012 Jun;50(4):328-32. doi: 10.1016/j.bjoms.2011.06.009. Epub 2011 Jul 26.

PMID:
21794962
27.

Long-term safety of growth hormone replacement after CNS irradiation.

Mackenzie S, Craven T, Gattamaneni HR, Swindell R, Shalet SM, Brabant G.

J Clin Endocrinol Metab. 2011 Sep;96(9):2756-61. doi: 10.1210/jc.2011-0112. Epub 2011 Jun 29.

PMID:
21715535
28.

Late-onset bowel dysfunction after pelvic radiotherapy: a national survey of current practice and opinions of clinical oncologists.

Henson CC, Andreyev HJ, Symonds RP, Peel D, Swindell R, Davidson SE.

Clin Oncol (R Coll Radiol). 2011 Oct;23(8):552-7. doi: 10.1016/j.clon.2011.04.002. Epub 2011 May 6.

PMID:
21550216
29.

Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer.

Choudhury A, Swindell R, Logue JP, Elliott PA, Livsey JE, Wise M, Symonds P, Wylie JP, Ramani V, Sangar V, Lyons J, Bottomley I, McCaul D, Clarke NW, Kiltie AE, Cowan RA.

J Clin Oncol. 2011 Feb 20;29(6):733-8. doi: 10.1200/JCO.2010.31.5721. Epub 2011 Jan 4.

PMID:
21205754
30.

YY1 expression predicts favourable outcome in follicular lymphoma.

Naidoo K, Clay V, Hoyland JA, Swindell R, Linton K, Illidge T, Radford JA, Byers RJ.

J Clin Pathol. 2011 Feb;64(2):125-9. doi: 10.1136/jcp.2010.078188. Epub 2010 Nov 25.

PMID:
21109702
31.

Early prostate cancer--which treatment do men prefer and why?

Anandadas CN, Clarke NW, Davidson SE, O'Reilly PH, Logue JP, Gilmore L, Swindell R, Brough RJ, Wemyss-Holden GD, Lau MW, Javle PM, Ramani VA, Wylie JP, Collins GN, Brown S, Cowan RA; North West Uro-oncology Group.

BJU Int. 2011 Jun;107(11):1762-8. doi: 10.1111/j.1464-410X.2010.09833.x. Epub 2010 Nov 17.

32.

Symptoms experienced by cancer patients during the first year from diagnosis: patient and informal caregiver ratings and agreement.

Molassiotis A, Zheng Y, Denton-Cardew L, Swindell R, Brunton L.

Palliat Support Care. 2010 Sep;8(3):313-24. doi: 10.1017/S1478951510000118.

PMID:
20875175
33.

Phase II study of short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance capecitabine in advanced colorectal cancer: XelQuali study.

Waddell T, Gollins S, Soe W, Valle J, Allen J, Bentley D, Morris J, Lloyd A, Swindell R, Taylor MB, Saunders MP.

Cancer Chemother Pharmacol. 2011 May;67(5):1111-7. doi: 10.1007/s00280-010-1322-0. Epub 2010 Jul 30.

PMID:
20676676
34.

Mucosal melanoma of the head and neck: radiotherapy or surgery?

Douglas CM, Malik T, Swindell R, Lorrigan P, Slevin NJ, Homer JJ.

J Otolaryngol Head Neck Surg. 2010 Aug;39(4):385-92.

PMID:
20643003
35.

Tumour budding and a low host inflammatory response are associated with a poor prognosis in oesophageal and gastro-oesophageal junction cancers.

Brown M, Sillah K, Griffiths EA, Swindell R, West CM, Page RD, Welch IM, Pritchard SA.

Histopathology. 2010 Jun;56(7):893-9. doi: 10.1111/j.1365-2559.2010.03559.x.

PMID:
20636792
36.

Development of a patient-reported questionnaire for collecting toxicity data following prostate brachytherapy.

Farnell DJ, Mandall P, Anandadas C, Routledge J, Burns MP, Logue JP, Wylie JP, Swindell R, Livsey J, West CM, Davidson SE.

Radiother Oncol. 2010 Oct;97(1):136-42. doi: 10.1016/j.radonc.2010.05.011. Epub 2010 Jun 17.

PMID:
20561698
37.

Electroglottogram approximate entropy: a novel single parameter for objective voice assessment.

Douglas CM, Moore C, Manickam K, Lee L, Sykes A, Carr A, Jones S, Jones J, Swindell R, Homer JJ, Slevin N.

J Laryngol Otol. 2010 May;124(5):520-8. doi: 10.1017/S0022215109992787. Epub 2010 Feb 4.

PMID:
20128940
38.

Can synchronous chemotherapy be added to accelerated hypofractionated radiotherapy in patients with base of tongue cancer?

Jegannathen A, Swindell R, Yap B, Lee L, Sykes A, Mais K, Sanghera P, Hartley A, Glaholm J, Slevin N.

Clin Oncol (R Coll Radiol). 2010 Apr;22(3):185-91. doi: 10.1016/j.clon.2009.12.007. Epub 2010 Feb 8.

PMID:
20116980
39.

Efficacy of data capture for patient-reported toxicity following radiotherapy for prostate or cervical cancer.

Farnell DJ, Routledge J, Hannon R, Logue JP, Cowan RA, Wylie JP, Barraclough LH, Livsey JE, Swindell R, Davidson SE.

Eur J Cancer. 2010 Feb;46(3):534-40. doi: 10.1016/j.ejca.2009.11.017. Epub 2009 Dec 21.

PMID:
20022742
40.

Primary radiotherapy for carcinoma of the retromolar trigone: a useful alternative to surgery.

Bayman NA, Sykes AJ, Bonington S, Blackburn T, Patel M, Swindell R, Slevin NJ.

Clin Oncol (R Coll Radiol). 2010 Mar;22(2):119-24. doi: 10.1016/j.clon.2009.10.017. Epub 2009 Dec 4.

PMID:
19962868
41.

Effectiveness of a home care nursing program in the symptom management of patients with colorectal and breast cancer receiving oral chemotherapy: a randomized, controlled trial.

Molassiotis A, Brearley S, Saunders M, Craven O, Wardley A, Farrell C, Swindell R, Todd C, Luker K.

J Clin Oncol. 2009 Dec 20;27(36):6191-8. doi: 10.1200/JCO.2008.20.6755. Epub 2009 Nov 16.

PMID:
19917849
42.

Clinical features of oral chemotherapy: results of a longitudinal prospective study of breast and colorectal cancer patients receiving capecitabine in the UK.

Brearley SG, Craven O, Saunders M, Swindell R, Molassiotis A.

Eur J Cancer Care (Engl). 2010 Jul;19(4):425-33. doi: 10.1111/j.1365-2354.2009.01114.x. Epub 2009 Aug 20.

PMID:
19708942
43.

Preoperative downstaging chemoradiation with concurrent irinotecan and capecitabine in MRI-defined locally advanced rectal cancer: a phase I trial (NWCOG-2).

Gollins SW, Myint S, Susnerwala S, Haylock B, Wise M, Topham C, Samuel L, Swindell R, Morris J, Mason L, Levine E.

Br J Cancer. 2009 Sep 15;101(6):924-34. doi: 10.1038/sj.bjc.6605258. Epub 2009 Aug 18.

44.

Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study.

Valle JW, Wasan H, Johnson P, Jones E, Dixon L, Swindell R, Baka S, Maraveyas A, Corrie P, Falk S, Gollins S, Lofts F, Evans L, Meyer T, Anthoney A, Iveson T, Highley M, Osborne R, Bridgewater J.

Br J Cancer. 2009 Aug 18;101(4):621-7. doi: 10.1038/sj.bjc.6605211.

45.

The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage.

Howell SJ, Searle C, Goode V, Gardener T, Linton K, Cowan RA, Harris MA, Hopwood P, Swindell R, Norman A, Kennedy J, Howell A, Wardley AM, Radford JA.

Br J Cancer. 2009 Aug 18;101(4):582-8. doi: 10.1038/sj.bjc.6605215.

46.

Prophylactic radiotherapy to intervention sites in mesothelioma: a systematic review and survey of UK practice.

Lee C, Bayman N, Swindell R, Faivre-Finn C.

Lung Cancer. 2009 Nov;66(2):150-6. doi: 10.1016/j.lungcan.2009.06.014. Epub 2009 Jul 23. Review.

PMID:
19628291
47.

Efficacy of photodynamic therapy as a treatment for Gorlin syndrome-related basal cell carcinomas.

Loncaster J, Swindell R, Slevin F, Sheridan L, Allan D, Allan E.

Clin Oncol (R Coll Radiol). 2009 Aug;21(6):502-8. doi: 10.1016/j.clon.2009.03.004. Epub 2009 Apr 23.

PMID:
19398312
48.

Shoulder morbidity after pectoralis major flap reconstruction for head and neck cancer.

Merve A, Mitra I, Swindell R, Homer JJ.

Head Neck. 2009 Nov;31(11):1470-6. doi: 10.1002/hed.21116.

PMID:
19384934
49.

The impact of radiotherapy late effects on quality of life in gynaecological cancer patients.

Barker CL, Routledge JA, Farnell DJ, Swindell R, Davidson SE.

Br J Cancer. 2009 May 19;100(10):1558-65. doi: 10.1038/sj.bjc.6605050. Epub 2009 Apr 21.

50.

Ultrasound imaging to assess inter- and intra-fraction motion during bladder radiotherapy and its potential as a verification tool.

McBain CA, Green MM, Stratford J, Davies J, McCarthy C, Taylor B, McHugh D, Swindell R, Khoo V, Price P.

Clin Oncol (R Coll Radiol). 2009 Jun;21(5):385-93. doi: 10.1016/j.clon.2009.01.016. Epub 2009 Mar 17.

PMID:
19282158

Supplemental Content

Loading ...
Support Center